Probiotic and Lifestyle Modification in Obese Pediatrics with Non-Alcoholic Fatty Liver Disease

Authors

  • Pooja Goyal Lovely Professional University, Phagwara, Punjab https://orcid.org/0000-0001-9209-2579
  • Babu Ram Thapa Maharishi Markandeshwar Medical Institute of Medical Sciences & Research (MMMISR) Mullana Ambala, Haryana
  • Neeta Raj Sharma Lovely Professional University, Phagwara, Punjab
  • Anmol Bhatia Post Graduate Institute of Medical Education and Research, Chandigarh https://orcid.org/0000-0003-4630-5742

DOI:

https://doi.org/10.47203/IJCH.2019.v31i03.022

Keywords:

Probiotic, Lifestyle

Abstract

In the article, “Probiotic and Lifestyle Modification in Obese Pediatrics with Non-Alcoholic Fatty Liver Disease” [1] which appears in Volume 31, Issue 1 of Indian J Community Health, there is a correction in the disclosure of the name of the drug used in the article. At the time of the publication, we were not aware of any legal issues related to the product and the brand, otherwise we would have taken due care and would have mentioned about the “De Simone Formulation” in the article instead of the VSL#3 product. Also, the references we provided in the published article on the usage of VSL#3 in several indications should have been attributed to the De Simone Formulation.

We used the original probiotic formulation (containing De Simone Formulation) in our study that was invented by Prof. Claudio De Simone,(2) and not the new VSL#3 which is a quite different product, as ruled by the US Federal Court. (3) This change does not affect the study of the paper. The authors would like to apologize for any inconvenience caused.

Downloads

Download data is not yet available.

References

Goyal P, Thapa B, Sharma N, Bhatia A. Probiotic and Lifestyle Modification in Obese Pediatrics with Non-Alcoholic Fatty Liver Disease. Indian J Community Health [Internet]. 31Mar.2019 [cited 20Jul.2019];31(1):50 -56. Available from: http://www.iapsmupuk.org/journal/index.php/IJCH/article/view/1031

De Simone C. Letter: what gastroenterologists should know about VSL#3. Aliment Pharmacol Ther. 2018 Mar;47(5):698-699. doi: 10.1111/apt.14515. PubMed PMID: 29417631.[PubMed]

https://www.classaction.org/news/class-action-accuses-pharma-companies-of-secretly-reformulating-vsl3-probiotics-product

Downloads

Published

2019-09-30

How to Cite

1.
Goyal P, Thapa BR, Sharma NR, Bhatia A. Probiotic and Lifestyle Modification in Obese Pediatrics with Non-Alcoholic Fatty Liver Disease. Indian J Community Health [Internet]. 2019 Sep. 30 [cited 2024 May 24];31(3):427. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/1193

Issue

Section

Erratum